USPTO Grants Sherlock Biosciences Priority Patent for CRISPR-Based Diagnostics
The USPTO granted Sherlock Biosciences a patent for the diagnostic use of the Cas12 enzyme, establishing it as CRISPR diagnostics provider.
Read MorePosted by Andy Lundin | Feb 21, 2023 | Amplification Technologies |
The USPTO granted Sherlock Biosciences a patent for the diagnostic use of the Cas12 enzyme, establishing it as CRISPR diagnostics provider.
Read MorePosted by Andy Lundin | Feb 17, 2023 | Covid 19 |
The Rockefeller Foundation has reached an agreement to extend a program that delivers free at-home COVID tests to at-risk communities.
Read MorePosted by Chris Wolski | Feb 15, 2023 | Covid 19, POC Rapid Assays, POC Reagents & Test Kits |
CLP Editor Chris Wolski recently took a trip bookended by COVID testing delivering him much needed peace of mind.
Read MorePosted by Andy Lundin | Feb 6, 2023 | Leukemia |
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients.
Read MorePosted by Andy Lundin | Feb 3, 2023 | Covid 19 |
Immunexpress detailed a study that validated the use of its SeptiCyte RAPID as a triaging tool for COVID patients requiring hospitalization.
Read More